Latham & Watkins has advised the lead managers on the offering. Linklaters advised Biocon Biologics. Biocon Biologics Plc, a wholly owned subsidiary of Biocon Biologics Limited...
Biocon Biologics’ $800 Million High Yield Bond Issuance
SK Bioscience’s Acquisition of IDT Biologika
Sullivan & Cromwel represented SK Bioscience in the transaction. South Korea-based vaccine developer SK Bioscience has agreed to acquire, through its German subsidiary, a 60 percent...